InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+34.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Davidson Michael H., Director. Insider active across 3 companies, notably Tenax Therapeutics, INC.. Cumulatively, 10 filings have been recorded. Breakdown: 3 buys · 1 sell. Total volume traded: €154k. Activity tracked since 10 January 2022. The latest transaction was filed on 26 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Davidson Michael H.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
443,707 sharesOrdinary SharesSEC:0001193125-26-085947:0
64,708 sharesOrdinary SharesSEC:0001193125-26-078718:0
11,582 sharesOrdinary SharesSEC:0001193125-26-009272:0
30,992 shares0Ordinary SharesSEC:0000950170-25-046934:0
123,529 sharesOrdinary SharesSEC:0000950170-25-003022:0
5,000 shares@ US$16.2747.6% of flowOrdinary SharesSEC:0000950170-24-099871:0
Canonical exit: 18 Nov 2024 (T+90)
2,500 sharesCommon StockSEC:0001654954-24-010192:0
Canonical exit: 6 Nov 2024 (T+90)
5,000 shares@ US$17.261752.4% of flowOrdinary SharesSEC:0000950170-24-076468:0
Canonical exit: 18 Sept 2024 (T+90)
65,430 shares0Common StockSEC:0001573785-22-000002:0
512,000 sharesCommon StockSEC:0001654954-21-006926:0
10 of 10 declarations
About Davidson Michael H.
Davidson Michael H. is a Director and has 10 filings in total. Across the 10 recent filings we hold, from 2021-06-15 to 2026-03-02, the record shows EUR 153718 of purchases and EUR 0 of sales, mainly in NewAmsterdam Pharma Co N.V., with roles also at Tenax Therapeutics, INC. and Caladrius Biosciences, INC.
